Literature DB >> 15980616

In vivo imaging of amyloid-beta deposits in mouse brain with multiphoton microscopy.

Jesse Skoch1, Gregory A Hickey, Stephen T Kajdasz, Bradley T Hyman, Brian J Bacskai.   

Abstract

With the advent of transgenic mouse models expressing cortical amyloid pathology, the potential to study its progression in an intact brain has been realized. Multiphoton microscopy provides a non-destructive means of imaging with micron resolution up to 500 microm deep into the cortex. We detail a surgical procedure and discuss a multiphoton imaging approach that allows for labeling and chronic visualization of amyloid-beta deposits through a cranial window. The ability to monitor these hallmarks of Alzheimer's disease enables studies aimed at evaluating the efficacy of treatment and prevention strategies.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15980616     DOI: 10.1385/1-59259-874-9:349

Source DB:  PubMed          Journal:  Methods Mol Biol        ISSN: 1064-3745


  26 in total

1.  Studying protein degradation pathways in vivo using a cranial window-based approach.

Authors:  Vivek K Unni; Darius Ebrahimi-Fakhari; Charles R Vanderburg; Pamela J McLean; Bradley T Hyman
Journal:  Methods       Date:  2010-12-25       Impact factor: 3.608

Review 2.  Invited review article: Imaging techniques for harmonic and multiphoton absorption fluorescence microscopy.

Authors:  Ramón Carriles; Dawn N Schafer; Kraig E Sheetz; Jeffrey J Field; Richard Cisek; Virginijus Barzda; Anne W Sylvester; Jeffrey A Squier
Journal:  Rev Sci Instrum       Date:  2009-08       Impact factor: 1.523

3.  Abnormal synaptic Ca(2+) homeostasis and morphology in cortical neurons of familial hemiplegic migraine type 1 mutant mice.

Authors:  Katharina Eikermann-Haerter; Michal Arbel-Ornath; Nilufer Yalcin; Esther S Yu; Kishore V Kuchibhotla; Izumi Yuzawa; Eloise Hudry; Carli R Willard; Mihail Climov; Fatmagul Keles; Arianna M Belcher; Buse Sengul; Andrea Negro; Isaac A Rosen; Andrea Arreguin; Michel D Ferrari; Arn M J M van den Maagdenberg; Brian J Bacskai; Cenk Ayata
Journal:  Ann Neurol       Date:  2015-07-06       Impact factor: 10.422

4.  Development and screening of contrast agents for in vivo imaging of Parkinson's disease.

Authors:  Krista L Neal; Naomi B Shakerdge; Steven S Hou; William E Klunk; Chester A Mathis; Evgueni E Nesterov; Timothy M Swager; Pamela J McLean; Brian J Bacskai
Journal:  Mol Imaging Biol       Date:  2013-10       Impact factor: 3.488

5.  Four-dimensional microglia response to anti-Aβ treatment in APP/PS1xCX3CR1/GFP mice.

Authors:  Monica Garcia-Alloza; Laura A Borrelli; Diana H Thyssen; Suzanne E Hickman; Joseph El Khoury; Brian J Bacskai
Journal:  Intravital       Date:  2013-04-01

6.  Impaired spine stability underlies plaque-related spine loss in an Alzheimer's disease mouse model.

Authors:  Tara L Spires-Jones; Melanie Meyer-Luehmann; Jennifer D Osetek; Phillip B Jones; Edward A Stern; Brian J Bacskai; Bradley T Hyman
Journal:  Am J Pathol       Date:  2007-08-23       Impact factor: 4.307

7.  Dendritic spine abnormalities in amyloid precursor protein transgenic mice demonstrated by gene transfer and intravital multiphoton microscopy.

Authors:  Tara L Spires; Melanie Meyer-Luehmann; Edward A Stern; Pamela J McLean; Jesse Skoch; Paul T Nguyen; Brian J Bacskai; Bradley T Hyman
Journal:  J Neurosci       Date:  2005-08-03       Impact factor: 6.167

8.  Abeta plaques lead to aberrant regulation of calcium homeostasis in vivo resulting in structural and functional disruption of neuronal networks.

Authors:  Kishore V Kuchibhotla; Samuel T Goldman; Carli R Lattarulo; Hai-Yan Wu; Bradley T Hyman; Brian J Bacskai
Journal:  Neuron       Date:  2008-07-31       Impact factor: 17.173

9.  In vivo imaging of alpha-synuclein in mouse cortex demonstrates stable expression and differential subcellular compartment mobility.

Authors:  Vivek K Unni; Tamily A Weissman; Edward Rockenstein; Eliezer Masliah; Pamela J McLean; Bradley T Hyman
Journal:  PLoS One       Date:  2010-05-11       Impact factor: 3.240

10.  Existing plaques and neuritic abnormalities in APP:PS1 mice are not affected by administration of the gamma-secretase inhibitor LY-411575.

Authors:  Monica Garcia-Alloza; Meenakshi Subramanian; Diana Thyssen; Laura A Borrelli; Abdul Fauq; Pritam Das; Todd E Golde; Bradley T Hyman; Brian J Bacskai
Journal:  Mol Neurodegener       Date:  2009-05-06       Impact factor: 14.195

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.